These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9673760

  • 1. The role of ifosfamide in paediatric cancer.
    Advani SH.
    Aust N Z J Med; 1998 Jun; 28(3):410-3. PubMed ID: 9673760
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer.
    Ingle JN, Krook JE, Mailliard JA, Hartmann LC, Wieand HS.
    Am J Clin Oncol; 1995 Dec; 18(6):498-501. PubMed ID: 8526193
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Ifosfamide in pediatric malignancy--experiences in the Northern Israel Oncology Center].
    Roguin A, Ben Arush MW, Higasi A, Kuten A.
    Harefuah; 1996 Apr 15; 130(8):511-4, 584. PubMed ID: 8765870
    [Abstract] [Full Text] [Related]

  • 8. Ifosfamide in the treatment of pediatric malignancies.
    Voûte PA, van den Berg H, Behrendt H, Michiels E, de Kraker J.
    Semin Oncol; 1996 Jun 15; 23(3 Suppl 7):8-11. PubMed ID: 8711502
    [Abstract] [Full Text] [Related]

  • 9. Phase II trial of ifosfamide in children with malignant solid tumors.
    Pratt CB, Horowitz ME, Meyer WH, Etcubanas E, Thompson EI, Douglass EC, Wilimas JA, Hayes FA, Green AA.
    Cancer Treat Rep; 1987 Feb 15; 71(2):131-5. PubMed ID: 3100034
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Continuous subcutaneous administration of mesna to prevent ifosfamide-induced hemorrhagic cystitis.
    Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J.
    Semin Oncol; 1996 Jun 15; 23(3 Suppl 6):97-8. PubMed ID: 8677458
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
    Kushner DM, Webster KD, Belinson JL, Rybicki LA, Kennedy AW, Markman M.
    Gynecol Oncol; 2000 Aug 15; 78(2):221-7. PubMed ID: 10926807
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acute pancreatitis induced by ifosfamide therapy.
    Garg R, Agarwala S, Bhatnagar V.
    J Pediatr Surg; 2010 Oct 15; 45(10):2071-3. PubMed ID: 20920734
    [Abstract] [Full Text] [Related]

  • 17. Treatment of advanced malignancies with ifosfamide under protection with mesna.
    Li GC, Brock N, Li JQ, Guan ZZ, He YJ.
    Int J Clin Pharmacol Res; 1988 Oct 15; 8(1):55-67. PubMed ID: 3130316
    [Abstract] [Full Text] [Related]

  • 18. Ifosfamide and paediatrics: should this marriage be saved?
    Womer RB.
    Eur J Cancer; 1996 Jun 15; 32A(7):1100-1. PubMed ID: 8758237
    [No Abstract] [Full Text] [Related]

  • 19. Phase I trial of a 24-h continuous infusion of ifosfamide/mesna in acute lymphoblastic leukemia.
    Otero JC, Solidoro A, Casanova L, Vallejos C, Rodriguez W.
    J Exp Ther Oncol; 1996 Mar 15; 1(2):84-7. PubMed ID: 9414391
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.